Champions Oncology (CSBR) Free Cash Flow (2010 - 2026)

Champions Oncology's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 526.84% year-over-year to -$1.5 million; the TTM figure through Jan 2026 stood at $4.1 million (up 388.56% YoY), while the FY2025 annual figure was $7.2 million, up 217.14% from the prior year.
• Free Cash Flow was -$1.5 million for Q1 2026 at Champions Oncology, up from -$1.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $6.8 million in Q2 2025 to a low of -$4.7 million in Q3 2023.
• Historically, Free Cash Flow has averaged $213235.3 across 5 years, with a median of $290000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow sank 600.69% in 2023, then surged 474.83% in 2025.
• A 5-year view of Free Cash Flow shows it stood at $2.7 million in 2022, then slumped by 80.98% to $510000.0 in 2023, then tumbled by 155.49% to -$283000.0 in 2024, then plunged by 504.95% to -$1.7 million in 2025, then grew by 11.74% to -$1.5 million in 2026.
• The last three Free Cash Flow figures came in at -$1.5 million (Q1 2026), -$1.7 million (Q4 2025), and $554000.0 (Q3 2025), per Business Quant data.